CKAP2L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.811000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.482800E-01
Normal-vs-Stage2
2.473600E-01
Normal-vs-Stage3
8.221000E-01
Normal-vs-Stage4
3.457200E-01
Stage1-vs-Stage2
2.766200E-01
Stage1-vs-Stage3
7.113200E-01
Stage1-vs-Stage4
4.589600E-01
Stage2-vs-Stage3
2.279200E-01
Stage2-vs-Stage4
9.715200E-01
Stage3-vs-Stage4
3.208000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.767000E-01
Normal-vs-AfricanAmerican
3.193600E-01
Normal-vs-Asian
3.133600E-01
Caucasian-vs-AfricanAmerican
5.822200E-01
Caucasian-vs-Asian
3.432000E-02
AfricanAmerican-vs-Asian
6.337600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.961000E-01
Normal-vs-Female
2.736400E-01
Male-vs-Female
9.059800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.593000E-01
Normal-vs-Age(41-60Yrs)
2.291600E-01
Normal-vs-Age(61-80Yrs)
2.969400E-01
Normal-vs-Age(81-100Yrs)
2.923000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.956170E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.366400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.522200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.587600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.474400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.806800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.694800E-01
Normal-vs-Daily Drinker
2.943000E-01
Normal-vs-Weekly Drinker
3.275600E-01
Normal-vs-Occasional Drinker
2.536400E-01
Normal-vs-Social Drinker
3.415000E-01
Non Drinker-vs-Daily Drinker
8.158400E-01
Non Drinker-vs-Weekly Drinker
6.054200E-01
Non Drinker-vs-Occasional Drinker
2.274400E-01
Non Drinker-vs-Social Drinker
4.071600E-01
Daily Drinker-vs-Weekly Drinker
7.144800E-01
Daily Drinker-vs-Occasional Drinker
2.894800E-01
Daily Drinker-vs-Social Drinker
4.924800E-01
Weekly Drinker-vs-Occasional Drinker
5.722200E-01
Weekly Drinker-vs-Social Drinker
7.770600E-01
Occasional Drinker-vs-Social Drinker
8.046800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.006800E-01
Normal-vs-Grade 2
7.085600E-01
Normal-vs-Grade 3
7.736000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.823420E-04
Grade 1-vs-Grade 3
9.90359999999413E-05
Grade 1-vs-Grade 4
6.006800E-01
Grade 2-vs-Grade 3
1.503220E-01
Grade 2-vs-Grade 4
7.085600E-01
Grade 3-vs-Grade 4
7.736000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.459000E-01
Normal-vs-NonDiabetic
2.726200E-01
Diabetic-vs-NonDiabetic
3.839000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.254960E-01
Normal-vs-NoPancreatitis
3.246800E-01
Pancreatitis-vs-NoPancreatitis
8.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.235600E-01
Normal-vs-N1
2.516400E-01
N0-vs-N1
5.820400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.882200E-02
Normal-vs-TP53-NonMutant
3.603800E-01
TP53-Mutant-vs-TP53-NonMutant
1.02610000052294E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
